971 related articles for article (PubMed ID: 23040455)
1. Erectile dysfunction.
Shamloul R; Ghanem H
Lancet; 2013 Jan; 381(9861):153-65. PubMed ID: 23040455
[TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies.
Phé V; Rouprêt M
Diabetes Metab; 2012 Feb; 38(1):1-13. PubMed ID: 22056307
[TBL] [Abstract][Full Text] [Related]
3. [Erectile dysfunction: how can you help?].
Kaminsky A; Sperling H
MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():88-91; quiz 92. PubMed ID: 22916432
[No Abstract] [Full Text] [Related]
4. [Erectile dysfunction].
Lyngdorf P
Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
[No Abstract] [Full Text] [Related]
5. Novel therapeutic targets for erectile dysfunction.
Williams SK; Melman A
Maturitas; 2012 Jan; 71(1):20-7. PubMed ID: 22154078
[TBL] [Abstract][Full Text] [Related]
6. [Erectile dysfunction and cardiovascular disease].
Urek R; Urek MC; Turek MC
Acta Med Croatica; 2006; 60(1):51-3. PubMed ID: 16802572
[TBL] [Abstract][Full Text] [Related]
7. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy.
Meller SM; Stilp E; Walker CN; Mena-Hurtado C
J Invasive Cardiol; 2013 Jun; 25(6):313-9. PubMed ID: 23735361
[TBL] [Abstract][Full Text] [Related]
8. [Sildenafil citrate in the treatment of men with erectile dysfunction].
Gamidov SI; Ovchinnikov RI; Popov AIu
Urologiia; 2014; (6):99-100, 102-3. PubMed ID: 25799737
[TBL] [Abstract][Full Text] [Related]
9. [Erectile dysfunction. New therapy options ante portas].
MMW Fortschr Med; 2002 Feb; 144(7):60. PubMed ID: 11887735
[No Abstract] [Full Text] [Related]
10. The role of prostaglandins in the aetiology and treatment of erectile dysfunction.
Khan MA; Thompson CS; Sullivan ME; Jeremy JY; Mikhailidis DP; Morgan RJ
Prostaglandins Leukot Essent Fatty Acids; 1999 Mar; 60(3):169-74. PubMed ID: 10359018
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
[TBL] [Abstract][Full Text] [Related]
12. Arterial erectile dysfunction: different severities of endothelial apoptosis between diabetic patients "responders" and "non responders" to sildenafil.
Condorelli RA; Calogero AE; Favilla V; Morgia G; Johnson EO; Castiglione R; Salemi M; Mongioí L; Nicoletti C; Duca Y; Di Mauro M; Vicari E; La Vignera S
Eur J Intern Med; 2013 Apr; 24(3):234-40. PubMed ID: 23357410
[TBL] [Abstract][Full Text] [Related]
13. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.
Kimura M; Caso JR; Bañez LL; Koontz BF; Gerber L; Senocak C; Donatucci CF; Vujaskovic Z; Moul JW; Polascik TJ
BJU Int; 2012 Dec; 110(11 Pt C):E931-8. PubMed ID: 22520165
[TBL] [Abstract][Full Text] [Related]
14. [Erectile dysfunction in cardiovascular diseases].
Girerd X
Praxis (Bern 1994); 2003 May; 92(20):950-5. PubMed ID: 12793121
[TBL] [Abstract][Full Text] [Related]
15. [Erectile dysfunction].
Ludwig G; Porst H; Wetterauer U; Sperling H; Hartmann U
Urologe A; 2006 Sep; 45 Suppl 4():157-62. PubMed ID: 16821058
[No Abstract] [Full Text] [Related]
16. [Organic basis of erectile impotence--evaluation and treatment possibilities].
Hauri D
Ther Umsch; 1998 Jun; 55(6):345-51. PubMed ID: 9658974
[TBL] [Abstract][Full Text] [Related]
17. Erectile Dysfunction.
Irwin GM
Prim Care; 2019 Jun; 46(2):249-255. PubMed ID: 31030826
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of cardiovascular risk factors in erectile dysfunction.
Walczak MK; Lokhandwala N; Hodge MB; Guay AT
J Gend Specif Med; 2002; 5(6):19-24. PubMed ID: 12503222
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutic management of erectile dysfunction.
Hawksworth DJ; Burnett AL
Clin Pharmacol Ther; 2015 Dec; 98(6):602-10. PubMed ID: 26352006
[TBL] [Abstract][Full Text] [Related]
20. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
Kaiho Y; Yamashita S; Arai Y
Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
